Philips has secured CE mark approval for its next-gen SmartCT imaging solution, designed to enhance real-time stroke and neurovascular care. Already in use in Japan and Canada, the technology will be showcased at LINNC Paris 2025.
Built for the Azurion neurobiplane system, SmartCT offers:
- Fast 3D imaging of brain tissue, vessels, and devices directly in the angio suite.
- Soft tissue helical cone-beam CT in as little as 8 seconds, with motion compensation.
- Dual-phase cerebral imaging for clear vessel and collateral flow visualization.
- Dual viewer capabilities for real-time image fusion and improved planning.
The system reduces the need for separate CT scans, supporting faster, more confident interventions during critical stroke procedures.
Follow MEDWIRE.AI for advanced imaging and stroke care updates.
